题名 | Recombinant FGF21 Protects Against Blood-Brain Barrier Leakage Through Nrf2 Upregulation in Type 2 Diabetes Mice |
作者 | |
发表日期 | 2019-04 |
发表期刊 | MOLECULAR NEUROBIOLOGY 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Article |
关键词 | Fibroblast growth factor 21 (FGF21) Diabetes Blood-brain barrier (BBB) Hyperglycemia Inflammation FGFR1 Nrf2 Keap1 |
其他关键词 | GENE-EXPRESSION ; PERMEABILITY ; INJURY ; HYPERGLYCEMIA ; INFLAMMATION ; STRESS ; CELLS ; KEAP1 |
摘要 | Blood-brain barrier (BBB) damage is a characteristic feature of diabetes mellitus pathology and plays significant roles in diabetes-associated neurological disorders. However, effective treatments for diabetes targeting BBB damage are yet to be developed. Fibroblast growth factor 21 (FGF21) is a potent regulator of lipid and glucose metabolism. In this study, we tested the hypothesis that recombinant FGF21 (rFGF21) administration may reduce type 2 diabetes (T2D)-induced BBB disruption via NF-E2-related factor-2 (Nrf2) upregulation. Our experimental results show that rFGF21 treatment significantly ameliorated BBB permeability and preserved junction protein expression in db/db mice in vivo. This protective effect was further confirmed by ameliorated transendothelial permeability and junction protein loss by rFGF21 under hyperglycemia and IL1 (HG-IL1) condition in cultured human brain microvascular endothelial cells (HBMEC) in vitro. We further reveal that rFGF21 can activate FGF receptor 1 (FGFR1) that increases its binding with Kelch ECH-associating protein 1 (Keap1), a repressor of Nrf2, thereby reducing Keap1-Nrf2 interaction leading to Nrf2 release. These data suggest that rFGF21 administration may decrease T2D-induced BBB permeability, at least in part via FGFR1-Keap1-Nrf2 activation pathway. This study may provide an impetus for development of therapeutics targeting BBB damage in diabetes. |
资助项目 | AHA Scientist Development GrantAmerican Heart Association [15SDG25550035]; National Institute of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01NS099539]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS099539] Funding Source: NIH RePORTER |
出版者 | SPRINGER |
出版地 | NEW YORK |
ISSN | 0893-7648 |
EISSN | 1559-1182 |
卷号 | 56期号:4页码:2314-2327 |
DOI | 10.1007/s12035-018-1234-2 |
页数 | 14 |
WOS类目 | Neurosciences |
WOS研究方向 | Neurosciences & Neurology |
WOS记录号 | WOS:000465498200002 |
收录类别 | SCIE ; PUBMED ; SCOPUS |
URL | 查看原文 |
Pubmed记录号 | 30022432 |
PMC记录号 | PMC6339597 |
Scopus记录号 | 2-s2.0-85050196255 |
ESI高被引论文 | 2020-01 ; 2020-03 |
通讯作者地址 | [Yu, Zhanyang]Neuroprotection Research Laboratory,Departments of Radiology and Neurology,Massachusetts General Hospital and Harvard Medical School,149 13th Street, Room 2401,Boston,02129,United States |
scopus学科分类 | Neurology;Cellular and Molecular Neuroscience |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/9016 |
专题 | 药学院(分析测试中心)_生物制药系_生物制药工程 |
通讯作者 | Yu, Zhanyang |
作者单位 | 1.Neuroprotection Research Laboratory,Departments of Radiology and Neurology,Massachusetts General Hospital and Harvard Medical School,149 13th Street, Room 2401,Boston,02129,United States; 2.School of Pharmaceutical Sciences,Key Laboratory of Biotechnology and Pharmaceutical Engineering,Wenzhou Medical University,Wenzhou,325035,China |
推荐引用方式 GB/T 7714 | Yu, Zhanyang,Lin, Li,Jiang, Yinghua,et al. Recombinant FGF21 Protects Against Blood-Brain Barrier Leakage Through Nrf2 Upregulation in Type 2 Diabetes Mice[J]. MOLECULAR NEUROBIOLOGY,2019,56(4):2314-2327. |
APA | Yu, Zhanyang., Lin, Li., Jiang, Yinghua., Chin, Ian., Wang, Xiaojie., ... & Wang, Xiaoying. (2019). Recombinant FGF21 Protects Against Blood-Brain Barrier Leakage Through Nrf2 Upregulation in Type 2 Diabetes Mice. MOLECULAR NEUROBIOLOGY, 56(4), 2314-2327. |
MLA | Yu, Zhanyang,et al."Recombinant FGF21 Protects Against Blood-Brain Barrier Leakage Through Nrf2 Upregulation in Type 2 Diabetes Mice".MOLECULAR NEUROBIOLOGY 56.4(2019):2314-2327. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论